Key Process Considerations for Therapeutic Oligonucleotides
September 9, 2021 - Cytiva

Single-Use Technologies Prove Effective for Viral Vector Process


August 30, 2021 - BioPharm International

The benefits of single-use technologies for upstream viral-vector processes clearly outweigh their disadvantages.

Cynthia A.

How Do I Fix Asymmetrical Chromatography Peaks?
August 30, 2021 - Cytiva

assymetrical peakAll good chromatography books say that

How to Optimize and Scale Up AAV Production
August 30, 2021 - Cytiva

Sanitization of AxiChromâ„¢ Columns Packed with Chromatography Re


August 30, 2021 - Cytiva AxiChrom

Achieving the Required Buffer Quality with Inline Conditioning
August 30, 2021 - Cytiva

Cell-free Expression Systems Pose Cell Culture Alternative
August 30, 2021 - BioPharm International Cell-free expression is promising in preclinical applications, but still presents challenges to scale up for commercial production.

Novavax Reports on Two Vaccine Efficacy Studies
July 29, 2021 - BioPharm International

Novavax’s C

Troubleshooting Protein Purity Issues – Top Tips
July 29, 2021 - Cytiva

Cytiva and Pall Corporation Investing 1.5 Billion USD Over Two Ye


July 29, 2021 - Cytiva
Click here to read more >>

Previous PageNext Page